It is a pharma public limited company based in Hyderabad, Telangana, India, established in 1980.
1980 | Hyderabad, Telangana, India | ActiveCognex Pharma Limited, a active public limited company, was established on 14 May 1980 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230TG1980PLC002680. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.30 Cr and a paid-up capital of ₹5.00 M.
It upholds a active non-compliant status. Its leadership includes Satyanarayana Gangavaram (Managing Director), Bhaskar Reddy Atla (Additional Director), Naga Raju Chanda (Additional Director). Past directors included Ravi Krishna Subbarao Gade. It holds ₹4.44 Cr open charges and no settled loans. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at Flat No.303, Prithvi Style Homes, Kamalanagar, Ecil, Hyderabad, Telangana, 500062.
U24230TG1980PLC002680
002680
14 May 1980
₹2.30 Cr
₹5.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Cognex Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satyanarayana Gangavaram | Managing Director | 16 Oct 1989 | Current |
| Bhaskar Reddy Atla | Additional Director | 28 Mar 2018 | Current |
| Naga Raju Chanda | Additional Director | 10 Jan 2018 | Current |
| Sampath Vijayaraghavan | Director | 27 Oct 2005 | Current |
| Bhaskar Anand Swamy Poralla | Director | 16 Oct 1989 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jan 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cognex Pharma Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 78.66% increase in profit. The company's net worth dipped by a decrease of 2.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Cognex Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹44,435,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2003 | Punjab National Bank | ₹1.50 M | Open |
| 22 Mar 2003 | Punjab National Bank | ₹3.59 Cr | Open |
| 07 Aug 1995 | State Bank Of India | ₹1.52 M | Open |
| 04 Dec 1991 | A.P.S.F.C. Chirag Ali Lane | ₹1.79 M | Open |
| 17 May 1990 | Andhra Bank | ₹3.51 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Cognex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cognex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cognex Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cognex Pharma Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was recorded as a recent event.
Cognex Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad. was recorded as a recent event.
Progress on Bhaskar Reddy Atla was appointed as a Additional Director was appointed as a Additional Director on 28 Mar 2018 & has been associated with this company since 7 years 7 months . was documented.
The activity Naga Raju Chanda was appointed as a Additional Director was appointed as a Additional Director on 10 Jan 2018 & has been associated with this company since 7 years 10 months . was completed.
The activity A charge with Punjab National Bank of Rs. 3.59 Cr registered on 22 Mar 2003 with Charge ID 90117810 was modified on 07 Jul 2007. was completed.
The activity Sampath Vijayaraghavan was appointed as a Director was appointed as a Director on 27 Oct 2005 & has been associated with this company since 20 years 28 days . was completed.
The CIN of Cognex Pharma Limited is U24230TG1980PLC002680.
Cognex Pharma Limited is headquartered at Flat No.303, Prithvi Style Homes, Kamalanagar, Ecil, Hyderabad, Telangana, 500062.
Cognex Pharma Limited was incorporated on 14 May 1980.
The current directors of Cognex Pharma Limited are
The primary industry of Cognex Pharma Limited is Manufacturing.
Cognex Pharma Limited is unlisted.
The authorized capital of Cognex Pharma Limited is ₹2.30 Cr, and the paid-up capital is ₹5.00 M.
The compliance status of Cognex Pharma Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX